Granulocyte-macrophage colony-stimulating factor neutralisation in patients with axial spondyloarthritis in the UK (NAMASTE): a randomised, double-blind, placebo-controlled, phase 2 trial

Granulocyte-macrophage colony-stimulating factor neutralisation in patients with axial spondyloarthritis in the UK (NAMASTE): a randomised, double-blind, placebo-controlled, phase 2 trial

Visa andra versioner (1)

<p><strong>Background</p></strong> Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a proinflammatory cytokine overproduced in several inflammatory and autoimmune diseases, including axial spondyloarthritis. Namilumab is a human IgG1 monoclonal anti-GM-CSF antibod...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän:	Worth, C, Al-Mossawi, MH, MacDonald, J, Fisher, BA, Chan, A, Sengupta, R, Packham, J, Gaffney, K, Gullick, N, Cook, JA, Corn, TH, Teh, J, Machado, PM, Taylor, PC, Bowness, P
Materialtyp:	Journal article
Språk:	English
Publicerad:	Elsevier 2024

Liknande verk

A first in disease phase 2A trial of granulocyte monocyte colony stimulating factor neutralisation for axial spondyloarthritis (NAMASTE study)
av: Al-Mossawi, MH, et al.
Publicerad: (2021)

Granulocyte-macrophage colony-stimulating factor neutralisation in patients with axial spondyloarthritis in the UK (NAMASTE): a randomised, double-blind, placebo-controlled, phase 2 trial
av: Worth, C, et al.
Publicerad: (2024)

Novel therapeutic targets in axial spondyloarthritis
av: Worth, C, et al.
Publicerad: (2018)

„CORONA VIRUS HANDLING – ‘NAMASTE’“
av: Sande Smiljanov
Publicerad: (2022-06-01)

STRATEGI PROMOSI EVENT NAMASTE FESTIVAL
av: Arie Wibowo
Publicerad: (2015-11-01)

Rheumatological manifestation of diabetes: “Namaste” sign
av: M Mahesh, et al.
Publicerad: (2018-01-01)

BROMODOMAIN INHIBITORS REDUCE TH17-TYPE RESPONSES IN SPONDYLOARTHRITIS IN VITRO
av: Hammitzsch, A, et al.
Publicerad: (2014)

The role of natural killer cells, gamma delta T-cells and other innate immune cells in spondyloarthritis
av: Al-Mossawi, M, et al.
Publicerad: (2013)

The role of natural killer cells, gamma delta T-cells and other innate immune cells in spondyloarthritis.
av: Al-Mossawi, M, et al.
Publicerad: (2013)

Pathogenic immune responses in Spondyloarthritis
av: Al-Mossawi, M
Publicerad: (2016)

Namaste (counterbalancing) technique: Overcoming warping in costal cartilage
av: Kapil S. Agrawal, et al.
Publicerad: (2015-05-01)

Namaste position-an option for patient position in pediatric anorectal surgeries
av: Debasish Mitra, et al.
Publicerad: (2013-01-01)

HLA-B27 and KIR3DL2 Interactions Promote The Differentiation and Survival Of Proinflammatory T Cells In Spondyloarthritis
av: Ridley, A, et al.
Publicerad: (2013)

Single cell analysis of spondyloarthritis regulatory T cells identifies distinct synovial gene expression patterns and clonal fates
av: Simone, D, et al.
Publicerad: (2021)

Single cell analysis of spondyloarthritis regulatory T cells identifies distinct synovial gene expression patterns and clonal fates
av: Simone, D, et al.
Publicerad: (2021)

Spectrum of spondyloarthritis
av: Himanshu Pathak, et al.
Publicerad: (2020-01-01)

Initiatives: National Ayush Morbidity and Standardized Terminologies Electronic (NAMASTE) Portal
av: Saketh Ram Thrigulla, et al.
Publicerad: (2023-07-01)

Elevated type-17 cytokines are present in Axial Spondyloarthritis stool
av: Brough, I, et al.
Publicerad: (2024)

Anti-tumour necrosis factor therapy in seronegative spondyloarthritis.
av: Catherine, S, et al.
Publicerad: (2005)

Assessing fatigue in adults with axial spondyloarthritis: a systematic review of the quality and acceptability of patient-reported outcome measures
av: Pearson, N, et al.
Publicerad: (2018)

The role of HLA-B27 in spondyloarthritis.
av: Allen, R, et al.
Publicerad: (1999)

Namaste Theory: A Quantitative Grounded Theory on Religion and Spirituality in Mental Health Treatment
av: Holly K. Oxhandler
Publicerad: (2017-08-01)

Neutralising Neurophobia
av: Greg Lamb
Publicerad: (2018-03-01)

Qualitative interview study exploring the patient experience of living with axial spondyloarthritis and fatigue: difficult, demanding and draining
av: Pearson, N, et al.
Publicerad: (2022)

Namaste care in the home setting: developing initial realist explanatory theories and uncovering unintended outcomes
av: Joanne Atkinson, et al.
Publicerad: (2020-01-01)

Development of the Warwick axial spondyloarthritis fatigue and energy questionnaire (WASTEd)—a new patient-reported outcome measure
av: Pearson, NA, et al.
Publicerad: (2022)

HLA-B27: natural function and pathogenic role in spondyloarthritis.
av: McMichael, A, et al.
Publicerad: (2002)

The role of B27 heavy chain dimer immune receptor interactions in spondyloarthritis.
av: Kollnberger, S, et al.
Publicerad: (2009)

«FLARES» IN AXIAL SPONDYLOARTHRITIS
av: Sh. F. Erdes
Publicerad: (2016-07-01)

Progression of axial spondyloarthritis
av: Sh. F. Erdes, et al.
Publicerad: (2021-06-01)

Etanercept in axial spondyloarthritis
av: Gui Luo, et al.
Publicerad: (2022-11-01)

Unique trancriptome signatures and GM-CSF expression in lymphocytes from patients with spondyloarthritis
av: Al-Mossawi, M, et al.
Publicerad: (2017)

Activation-induced killer cell immunoglobulin-like receptor 3DL2 binding to HLA-B27 licenses pathogenic T cell differentiation in spondyloarthritis
av: Ridley, A, et al.
Publicerad: (2016)

Qualitative interview study exploring the patient experience of living with axial spondyloarthritis and fatigue: difficult, demanding and draining
av: Kirstie Haywood, et al.
Publicerad: (2022-02-01)

PHENOTYPIC CHARACTERIZATION OF NATURAL KILLER CELLS AND RECEPTORS IN SPONDYLOARTHRITIS
av: Chan, A, et al.
Publicerad: (2004)

Supplementary figures for "Inhibiting HLA-B27 homdimer-driven immune cell inflammation in Spondyloarthritis"
av: Bowness, P
Publicerad: (2012)

Serum granulocyte-macrophage colony-stimulating factor (GM-CSF) is increased in patients with active radiographic axial spondyloarthritis and persists despite anti-TNF treatment
av: Charalampos Papagoras, et al.
Publicerad: (2022-08-01)

Unique transcriptome signatures and GM-CSF expression in lymphocytes from patients with spondyloarthritis
av: M. H. Al-Mossawi, et al.
Publicerad: (2017-11-01)

Management of Axial Spondyloarthritis – Insights into Upadacitinib
av: Braun J, et al.
Publicerad: (2022-10-01)

Randomised, Double-Blind, Placebo-Controlled Study of Iguratimod in the Treatment of Active Spondyloarthritis
av: Yan Li, et al.
Publicerad: (2021-06-01)